ArticlePharmaceuticals (Basel, Switzerland)2026
Antitumor Activity of the ACC Inhibitor Firsocostat in Breast Cancer Cell Lines: A Proof-of-Concept In Vitro Study.
Simona Picerno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.